Regent Peak Wealth Advisors LLC Sells 188 Shares of Danaher Co. (NYSE:DHR)

Regent Peak Wealth Advisors LLC decreased its position in shares of Danaher Co. (NYSE:DHR) by 9.2% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,860 shares of the conglomerate’s stock after selling 188 shares during the period. Regent Peak Wealth Advisors LLC’s holdings in Danaher were worth $381,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Heck Capital Advisors LLC purchased a new stake in Danaher during the fourth quarter valued at about $27,000. Golden State Wealth Management LLC purchased a new stake in Danaher during the fourth quarter valued at about $31,000. Strategic Financial Concepts LLC purchased a new stake in Danaher during the fourth quarter valued at about $31,000. Pineridge Advisors LLC lifted its stake in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after purchasing an additional 57 shares during the last quarter. Finally, Kentucky Trust Co purchased a new stake in Danaher during the fourth quarter valued at about $34,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research firms recently issued reports on DHR. Barclays raised their target price on Danaher from $205.00 to $215.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 22nd. Guggenheim reissued a “buy” rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Jefferies Financial Group cut their target price on Danaher from $260.00 to $230.00 and set a “buy” rating on the stock in a research note on Tuesday, April 22nd. HSBC reduced their price target on shares of Danaher from $270.00 to $240.00 in a research report on Friday, April 25th. Finally, Robert W. Baird reduced their price target on shares of Danaher from $231.00 to $225.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Four analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $263.24.

Insider Transactions at Danaher

In related news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. This represents a 51.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This trade represents a 28.70% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $196.13 on Friday. The stock has a market cap of $140.36 billion, a PE ratio of 37.15, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The firm’s 50-day simple moving average is $191.34 and its two-hundred day simple moving average is $212.19.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion for the quarter, compared to the consensus estimate of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. Analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.65%. Danaher’s dividend payout ratio is presently 24.85%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.